Open access · CC-BY
via OpenAlex
Controversial effects of metformin on human physiology and pathophysiology
Shuo Fang, Qirui Liu, Yi Lu, Jian Zhang
Frontiers in Pharmacology · 2026
Abstract
Metformin is the first-line oral antihyperglycemic agent for type 2 diabetes mellitus (T2DM), with over 150 million individuals worldwide receiving treatment annually. Although synthesized in 1922, its clinical adoption began in the 1950s, and decades of widespread use have firmly established its efficacy in glycemic control and metabolic improvement. Nevertheless, growing evidence indicates that metformin exerts pleiotropic effects beyond glucose homeostasis-modulating neurocognitive function, gastrointestinal physiology, reproductive endocrinology, and cellular aging pathways. Many of these effects remain incompletely characterized, mechanistically ambiguous, or clinically inconsistent across populations. This review systematically synthesizes recent (2014-2024) preclinical and clinical evidence from PubMed and Google Scholar to critically evaluate the contested physiological and pathophysiological actions of metformin. We distinguish robustly replicated findings from preliminary or contradictory observations, clarify dose- and context-dependent mechanisms (e.g., mitochondrial vs. lysosomal AMPK activation), and highlight knowledge gaps impeding safe, personalized application. Emphasis is placed on reconciling mechanistic insights with real-world therapeutic outcomes-particularly regarding long-term safety, interindividual variability in pharmacokinetics (e.g., OCT/MATE transporter polymorphisms), and the need for prospective studies integrating multi-omics profiling and extended follow-up.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fphar.2026.1799374
- Canonical
- link ↗
- Fetched
- 2026-10-08 MST
Cite this
APA
Fang, S., Liu, Q., Lu, Y., & Zhang, J. (2026). Controversial effects of metformin on human physiology and pathophysiology. <em>Frontiers in Pharmacology</em>. https://doi.org/10.3389/fphar.2026.1799374
Vancouver
Fang S, Liu Q, Lu Y, Zhang J. Controversial effects of metformin on human physiology and pathophysiology. Frontiers in Pharmacology. 2026. doi:10.3389/fphar.2026.1799374.
BibTeX
@article{shuo2026Contro,
title = {Controversial effects of metformin on human physiology and pathophysiology},
author = {Shuo Fang and Qirui Liu and Yi Lu and Jian Zhang},
journal = {Frontiers in Pharmacology},
year = {2026},
doi = {10.3389/fphar.2026.1799374},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cells 2025
Open access · CC-BY
Neuroprotective Effects of Metformin Through the Modulation of Neuroinflammation and Oxidative Stress
Die Pharmazie 2025
Open access · CC-BY
Metformin and the molecular pathways of aging: Searching for the modern elixir of life
Preprints.org 2026
Preprint · CC-BY
Current Status of Senolytics and Senomorphics: Mechanistic Insights, Clinical Progress, and Future Directions
2026
Preprint
Current Status of Senolytics and Senomorphics: Mechanistic Insights, Clinical Progress, and Future Directions
Biocell 2026
Open access · OA
Metformin as a Geroprotective Agent: Multifaceted Mechanisms Targeting Cellular Senescence and Aging Hallmarks
International Journal of Environmental Sciences 2025
Open access · CC-BY